This trial will study the effects of Gabapentin on people with Bipolar Disorder who use marijuana. They will take the medication or a placebo for 17 days, and have 5 study visits with 2 MRI brain scans.
1 Primary · 0 Secondary · Reporting Duration: Baseline to end of treatment, approximately 17 days
Experimental Treatment
Non-Treatment Group
68 Total Participants · 3 Treatment Groups
Primary Treatment: Gabapentin · Has Placebo Group · Phase 2
Age 18 - 65 · All Participants · 6 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:New Jersey | 100.0% |
18 - 65 | 100.0% |
Did not meet criteria | 100.0% |